Home > Healthcare > Medical Devices > Therapeutic Devices > Therapeutic Hypothermia Systems Market

Therapeutic Hypothermia Systems Market Size

  • Report ID: GMI8457
  • Published Date: Mar 2024
  • Report Format: PDF

Therapeutic Hypothermia Systems Market Size

Therapeutic Hypothermia Systems Market size was valued at around USD 286.2 million in 2023 and is estimated to reach USD 433.2 million by 2032 with a CAGR of 4.8% over the forecast period. This robust market growth can be attributed to factors such as the increasing prevalence of cardiovascular and neurological disorders coupled with the growing awareness of the benefits of therapeutic hypothermia.

 

The rising prevalence of cardiovascular and neurological disorders has led to an expansion in the indications for therapeutic hypothermia. Clinical studies and medical guidelines increasingly recommend hypothermic therapy for conditions such as cardiac arrest, stroke, and traumatic brain injury, driving the demand for therapeutic hypothermia systems. For instance, according to the Sudden Cardiac Arrest Foundation, in 2022, there were more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the U.S.

 

Therapeutic hypothermia systems refer to medical devices designed to induce and maintain a controlled reduction in body temperature for therapeutic purposes. This deliberate cooling of the body, typically within a precise temperature range, is employed as a therapeutic intervention in various medical conditions, particularly those involving neurological and cardiovascular disorders.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Therapeutic hypothermia systems market size was USD 286.2 million in 2023 and is expected to reach USD 433.2 million by 2032 owing to the increasing prevalence of cardiovascular and neurological disorders worldwide.

Therapeutic hypothermia systems industry from the cooling devices segment recorded over USD 141.2 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to offering both, surface cooling methods as well as intravascular cooling catheters.

North America therapeutic hypothermia systems industry reached USD 115.9 million in 2023 due to the high incidence of conditions such as cardiac arrest, stroke, and traumatic brain injury in the region.

EM-MED Sp. z o.o. Sp. K., Gentherm Incorporated, International Biomedical Ltd., Phoenix Medical Systems Pvt. Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Stryker Corporation, and Terumo Corporation, are some of the major therapeutic hypothermia systems companies worldwide.

Therapeutic Hypothermia Systems Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 251
  • Countries covered: 22
  • Pages: 162
 Download Free Sample